Financial writer discusses Humana's premarket drop due to Cigna's share repurchase plans, impacting ...

Humana (HUM) stock in focus as company raises MA membership guidance with its Q3 2024 resuls despite setbacks this year. Read ...

Humana’s earnings beat Wall Street expectations, but the insurer said 2025 results might come in lower than analysts project, ...

The company said third-quarter earnings per share were $4.16 on revenue of $29.4 billion. Analysts anticipated earnings per ...

Humana (NYSE:HUM) quickly fell 5% in premarket trading at least party amid some Cigna (CI) comments about share repurchases.

The insurer said it doesn’t expect earnings growth next year due to significant investments it plans to make to boost MA ...

TD Cowen raised the firm’s price target on Humana (HUM) to $268 from $261 and keeps a Hold rating on the shares. The firm said the ...

Wells Fargo analyst Stephen Baxter lowered the firm’s price target on Humana (HUM) to $290 from $387 and keeps an Overweight rating on ...

Humana's Q3 EPS of $4.16 beat estimates but fell year-over-year. Revenue rose to $29.3 billion, driven by Medicare Advantage ...

Humana reported a $480 million profit and higher-than-expected growth of its Medicare Advantage business that has been hit with higher costs.

Humana updated its outlook for the year thanks to a third quarter in which it beat the Street on both earnings and revenue. | Humana updated its outlook for the year thanks to a third quarter in which ...

The executive comes with more than four decades of experience at the country's largest financial institutions.